Glycemics Flashcards
SULFONYLUREAS
Example Indications Mechanism of action Side Effects Contraindication/considerations
E- 2nd Gen- glyburide, glipizide, glimeperide [IDES]
I- DM2, fasting and postprandial
M- enhance insulin secretion by blocking ATP-sensitive K+ channels in cell membranes of pancreatic cells [pancreas] / Hepatic metabolize (CYP 450 2C9), renal excretion
S- hypoglycemia & weight gain; avoid alcohol
C- elderly patients (renal/hepatic) - lower dose
- *only tolbutamide requires dosage adjust
- inability to stimulate insulin release at extremely high glucose levels
NONSULFONYLRUEA SECRATGOGUES Example Indications Mechanism of action Side Effects Contraindication/considerations
E- glinides / meglitinides
I- DM 2, reduce post meal glucose levels
M- very similar to sulfonylureas, but shorter onset and duration; 15 minutes before meal
S- hypoglycemia
BIGUANIDES
Example Indications Mechanism of action Side Effects Contraindication/considerations
E- metformin; 500mg BID
I- DM 2, fasting and postprandial
M- decrease hepatic glucose production and increase insulin sensitivity in both hepatic and peripheral muscle tissue
S-GI (appetite, nausea, and diarrhea), b12 absorption
C- eGFR < 30; hold 24 hours before surgery; radiographic procedure; lactic acidosis
FIRST LINE therapy
THIAZOLIDINEDIONES (TZDs)
[great for cardio / fat but risky s/e]
Example Indications Mechanism of action Side Effects Contraindication/considerations
E- pioglitazone, rosiglitazone (-litazones)
– 15-30mg/day, increase up to 45 after 12 weeks (how long it takes to effect)
I- DM 2, Fasting and postprandial
M- increase insulin sensitivity by stimulating PPAR-Y
S- onset delayed several weeks (12 weeks); fluid retention and edema; weight gain, fractures, bladder CA
C- Heart Failure; piggy better for heart, rosi bad; monitor liver enzymes
ALPHA-GLUCOSIDASE INHIBITORS
Example Indications Mechanism of action Side Effects Contraindication/considerations
E- Acarbose; miglitol
–25mg TID w/ meals; advance 4-8 week intervals up to 100mg TID
I- DM 2, postprandial
M- small intestine, delay absorption; post prandial
S- GI – farts, abd discomfort, diarrhea
C- intestinal disease; high serum creatinine (> 2mg/dL)
DPP-4 INHIBITORS
Example Indications Mechanism of action Side Effects Contraindication/considerations
E- [GLIPTINS] sitagliptin, saxagliptin, linagliptin etc.
I- DM2; primarily post prandial
[GI TRACT]
M- w/ diet and exercise; inhibit DPP-4, which breaks down GLP-1 - more endogenous GLP-1 when eating
S-headache and nasopharyngitis (NOT Hypogly - indirect); pancreatitis
C- once daily med, reduce w/ renal impair
SGLT2 INHIBITORS
Example Indications Mechanism of action Side Effects Contraindication/considerations
E- (-glifozin); canagliflozin, dapagliflozin, empagliflozin
I- DM 2 [KIDNEY], fasting and postprandial
M-inhibition of SGLT2 in proximal tubules, reducing reabsorption of filtered glucose and lowers renal threshold for glucose which together cause increased urinary excretion of glucose and decreased plasma glucose
S- amputation? UTI and genital mycotic infxn; hypotension from osmotic diuresis; fractures and bladder CA; hyperkalemia, DKA**
C- good for cardiovascular; *monitor fluid volume status; ketoacidosis assessment
CENTRAL ACTING DOPAMINE ANTAGONIST
Example Indications Mechanism of action Side Effects Contraindication/considerations
E- Bromocriptine
I- DM 2, hypothalamus, Postprandial
M- improves insulin sensitivity
S- rhinitis, dizziness, asthenia, H/a, sinusitis, constipation, nausea
C- take 2 hours after waking in AM w/ food
contra- syncopal migraine and nursing women
CyP 34A inhibitor *** (fungals and HIV Meds - dont take; decrease for moderate)
BILE ACID SEQUESTRANTS
Example Indications Mechanism of action Side Effects Contraindication/considerations
E- Colesevelam (adjunctive), 1.875g BID
I- DM 2, fasting
M- binds bile acid in intestine
S- constipation and dyspepsia; fat soluble malabsorption
C- Drug-drug interactions r/t absorption (levo, glyburide, contraceptive, phenytoin, warfarin, digoxin; separate 4 hours from pills
INSULIN Regular (short-acting)
Type Onset Peak Duration Administration
“Bolus”; Regular (humulin, Novolin)
Onset - 30 minutes
Peak- 2-3 hours
Duration- 3-6 hours
Administration - IV or SQ
INSULIN Regular (short-acting)
Type Onset Peak Duration Administration
“Bolus”, Lispro, Aspart, Glulisin
Onset - 15-30 mins
Peak- ~1-3 hours
Duration - 3-4 hours
Administration- IV, SQ, (INH?)
INSULIN
Intermediate Acting
Type Onset Peak Duration Administration
“BASAL”, NPH
Onset - 2-4 hours
Peak- 4-6
Duration 8-12
Administration - SQ
INSULIN
Long-Acting
Type Onset Peak Duration Administration
“BASAL”, Glargine, Detemir, Degludec
Onset- 4-5 hours, no peak, 22-42 hours (Degludec longest)
SQ
Combination Therapy
NPH and Regular
NPH and lispro
NPH and humalog
Insulin Pump Rules
Required dose vs correction
REQUIRED 500 Rule (rapid-acting) 450 Rule (regular insulin) --> divide 500 by daily dose of insulin \_\_\_\_\_\_ CORRECTION 1800 rapid, 1500 regular --> 1800 by total daily insulin